Creo Medical Group PLC (LON:CREO) Insider Richard John Rees Acquires 4,712 Shares

Creo Medical Group PLC (LON:CREO) insider Richard John Rees purchased 4,712 shares of Creo Medical Group stock in a transaction dated Thursday, January 16th. The shares were bought at an average price of GBX 19 ($0.23) per share, for a total transaction of £895.28 ($1,103.78).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees acquired 98,000 shares of Creo Medical Group stock. The shares were purchased at an average price of GBX 20 ($0.25) per share, with a total value of £19,600 ($24,164.71).

Creo Medical Group Stock Performance

LON:CREO opened at GBX 18.50 ($0.23) on Wednesday. The company’s 50-day moving average is GBX 17.55 and its two-hundred day moving average is GBX 23.50. Creo Medical Group PLC has a 1-year low of GBX 12 ($0.15) and a 1-year high of GBX 43 ($0.53). The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19. The firm has a market capitalization of £66.93 million, a price-to-earnings ratio of -308.33 and a beta of 0.86.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.